| CTRI Number |
CTRI/2024/09/073351 [Registered on: 04/09/2024] Trial Registered Prospectively |
| Last Modified On: |
21/08/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Siddha |
| Study Design |
Other |
|
Public Title of Study
|
Clinical Evaluation of Siddha Medicine PIRANDAI VADAGAM for Deepana Silathuma Noi (Disorder in lipid profile) (DYSLIPIDEMIA) |
|
Scientific Title of Study
|
SINGLE CENTRIC NON RANDOMIZED OPEN CLINICAL TRIAL PHASE II IN DEEPANA SILATHUMA NOI (DYSLIPIDEMIA) WITH SIDDHA MEDICINE PIRANDAI VADAGAM AMONG PATIENTS ATTENDING OPD AT GOVERNMENT SIDDHA MEDICAL COLLEGE HOSPITAL CHENNAI |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dhildhar T |
| Designation |
PG scholar |
| Affiliation |
Government Siddha Medical College |
| Address |
Room no S1,Government Siddha Medical College,Arumbakkam,
Chennai.
Chennai TAMIL NADU 600106 India |
| Phone |
9790549422 |
| Fax |
|
| Email |
dhilu3010@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr N Anbu |
| Designation |
Professor and head of the department |
| Affiliation |
Government Siddha Medical College |
| Address |
Room no S1,Government Siddha Medical College,Arumbakkam,
Chennai
Chennai TAMIL NADU 600106 India |
| Phone |
9443279412 |
| Fax |
|
| Email |
nanbu.sumi@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr N Anbu |
| Designation |
Professor and head of the department |
| Affiliation |
Government Siddha Medical College |
| Address |
Room no S1,Government Siddha Medical College,Arumbakkam,
Chennai
Chennai TAMIL NADU 600106 India |
| Phone |
9443279412 |
| Fax |
|
| Email |
nanbu.sumi@gmail.com |
|
|
Source of Monetary or Material Support
|
|
Govt. Siddha Medical College, Arumbakkam, Chennai - 600 106 |
|
|
Primary Sponsor
|
| Name |
Dhildhar T |
| Address |
Department of Pothu Maruthuvam Government Siddha Medical
College Arumbakkam Chennai |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr T Dhildhar |
Government Siddha Medical College and hospital |
Department of PG Pothu maruthuvam, Room no S1, Arumbakkam, Chennai - 600 106.
Chennai
TAMIL NADU Chennai TAMIL NADU |
9790549422
dhilu3010@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee of Government Siddha Medical College Arumbakkam Chennai |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: E784||Other hyperlipidemia, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Nil |
Nil |
| Intervention |
Pirandai Vadagam |
500 mg, tds after food with hot water for 3 months |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients who have derangement in lipid profile |
|
| ExclusionCriteria |
| Details |
Patients who have history of pancreatitis, hypothyroidism, IHD, Stroke. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Normal in lipid profile assessed by blood investigation. |
The outcome will be assessed with in 12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Normal in BMI will be assessed as secondary outcome. |
Outcome may be expected in a period 12 weeks
|
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
09/09/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Statistical Analysis Plan Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [dhilu3010@gmail.com].
- For how long will this data be available start date provided 02-06-2025 and end date provided 31-12-2026?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Dyslipidemia is a very common lifestyle disorder.Dyslipidemia can have a number of clinical consequences, most notably premature atherosclerotic cardiovascular disease (ASCVD), and therefore important to appropriately diagnose and treat. In the siddha system of medicine Dyslipidemia is treated with a unique combination of medicine PIRANDAI VADAGAM which will be cost effective and reliable.The aim of this study is the management Deepana Silathuma Noi (Dyslipidemia) with the Siddha medicine PIRANDAI VADAGAM and the objective is to determine the therapeutic efficacy and safety profile of the Siddha medicine PIRANDAI VADAGAM in the treatment of Deepana Silathuma Noi (Dyslipidemia). As the literary evidences support the usage of drugs in the disease, hypothesis is created in such a way that the efficacy of PIRANDAI VADAGAM will be a better solution for the management of Deepana Silathuma Noi (Dyslipidemia) |